This scaremongering about mental health is depressing

Reluctant as I am to publicly criticise fellow journalists, I am making an exception for your recent article ‘Depressing truth about treating depression in the young’ (Apr 3).

The story contains at least one factual inaccuracy (escitalopram is not a component of Lexapro, it is the generic name for Lexapro) and two points of ambiguity (escitalopram is available in 5mg doses, regardless of what doses your reporter was prescribed; Mirtazapine is a NaSSA-class drug, not an SSRI). The story showed a poor understanding of both the SSRI class of antidepressants and the psychotherapeutic methods used in the treatment of depression.

Ultimately, the problem is this: if you lie to a doctor, you will receive inappropriate treatment. This is not news.